Vabysmo 6 MG/0.05 ML syringe 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQWM5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,822
Award facts
- Contract value 100% obligated
- $8,821.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,821.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml syringes. The delivery order, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, was not issued under a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense medical facilities worldwide.
DMS Pharmaceutical Group, registered in the System for Award Management since 2001, serves as a critical supplier within the federal pharmaceutical supply chain, distributing a wide range of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to support military healthcare operations. The vendor's PPV-G GEN V contract, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as a regional prime vendor contractor among multiple selected suppliers. The company's established performance across numerous delivery orders and its comprehensive product portfolio spanning oncology treatments, immunosuppressants, emergency medications, and specialty pharmaceuticals demonstrate its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQWM5?
SPE2DR26FQWM5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQWM5 worth?
The government has obligated $8,822 on SPE2DR26FQWM5.
Is contract SPE2DR26FQWM5 an order under another contract?
Yes. SPE2DR26FQWM5 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWM5 competed?
The extent of competition for SPE2DR26FQWM5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award